With progress in basic and clinical research on hepatic encephalopathy in cirrhosis worldwide, the Chinese Society of Hepatology of the Chinese Medical Association has invited experts in relevant fields to revise the 2018 "Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis." The updated guidelines provide recommendations for the clinical diagnosis, treatment, and both primary and secondary prevention of hepatic encephalopathy in cirrhosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11894390 | PMC |
| http://dx.doi.org/10.14218/JCTH.2024.00484 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024).
J Clin Transl Hepatol
March 2025
Department of Pathogenic Biology, Peking University Health Science Center, Beijing, China.
With progress in basic and clinical research on hepatic encephalopathy in cirrhosis worldwide, the Chinese Society of Hepatology of the Chinese Medical Association has invited experts in relevant fields to revise the 2018 "Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis." The updated guidelines provide recommendations for the clinical diagnosis, treatment, and both primary and secondary prevention of hepatic encephalopathy in cirrhosis.
View Article and Find Full Text PDFRat Model of Endogenous and Exogenous Hyperammonaemia Induced by Different Diets.
Int J Mol Sci
February 2025
Anara AB, 23132 Trelleborg, Sweden.
Two different diets able to induce dietary hyperammonaemia (a methionine-choline-deficient (MCD) diet and a methionine-deficient diet enriched with ammonium acetate (MAD + 20% ammonium acetate)) were tested in a rat model. The diets were shown to have different modes of action, inducing significant hyperammonaemia (HA) and growth retardation in the rats, with different metabolic consequences. The MCD diet resulted in the development of endogenous HA, with a decrease in bilirubin levels and an increase in hepatic fat content.
View Article and Find Full Text PDFHepatic encephalopathy - We are no longer those who believe that reality is what we perceive.
Hepatology
March 2025
Professor of Medicine and Surgery, Division of Gastroenterology and Hepatology and Comprehensive Transplant Center, Northwestern Medicine, Feinberg School of Medicine, 676 N. St. Clair St., Room 1900, Chicago, IL 60611, USA.
Chinese Medicine for the Treatment of Liver Cirrhosis: The Mechanism of Cellular Autophagy.
Am J Chin Med
March 2025
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100007, P. R. China.
Liver cirrhosis is a critical stage in the progression of various chronic liver diseases, often leading to severe complications such as ascites, hepatic encephalopathy, and a high mortality rate, and it thus poses a serious threat to patient life. The activation of hepatic stellate cells is a central driver of disease progression. Cellular autophagy, a lysosome-mediated degradation process, plays a key role in maintaining cellular function and dynamic homeostasis.
View Article and Find Full Text PDFMultiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit.
United European Gastroenterol J
March 2025
Liver Intensive Care Unit, Hepatogastroenterology Department, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
Introduction: Management of hepatic encephalopathy relies on the identification and control of precipitating factors (PF). The prognostic value of a PF is unknown, which we aimed to explore.
Patients And Methods: Single-center retrospective study of cirrhotic patients included in a prospective cohort admitted to an intensive care unit (ICU) between 2019 and 2022.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!